MedTrace Logo

Evaluation of the Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study

NCT07634146 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 920

Last updated 2026-06-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the impact of the Migraceutics® phase-specific dietary supplement regimen on quality of life, work productivity, and biomarkers in adult migraineurs.

Conditions

  • Migraine
  • Migraine Disease
  • Migraine Disorder
  • Migraine Headache
  • Migraine Disability
  • Migraine in Adults
  • Menstrual Migraine
  • Menstrual Migraine (MM) Headaches

Interventions

DIETARY_SUPPLEMENT

Foundational dietary supplement

Foundational dietary supplement, self-administered daily.

DIETARY_SUPPLEMENT

Luteal phase dietary supplement add-on

Add-on dietary supplement, self-administered to women with menstrual migraine during the luteal phase of their menstruation cycle.

DIETARY_SUPPLEMENT

Migraine phase dietary supplement add-on

Add-on dietary supplement, self-administered during the symptomatic migraine phase.

DIETARY_SUPPLEMENT

Reference dietary supplement

Reference comparator supplement, self-administered daily.

Sponsors & Collaborators

  • Miracle Wellness LLC

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-08
Primary Completion
2028-06-30
Completion
2028-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07634146 on ClinicalTrials.gov